Jürgen Betzing

Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients.

Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.

Acino AG engages in the development and manufacture of pharmaceutical products. It also offers services such as registration, procurement, contract manufacturing, packaging, and logistics. Its products include solid oral dosage forms, patches, as well as biodegradable and subcutaneous implants. The company was founded by Wilfried Fischer in 1997 and is headquartered in Miesbach, Germany.

Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany.

IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany.